Why Moderna Stock Is Soaring Today
Shares of Moderna (NASDAQ: MRNA) were soaring 24.1% higher as of 10:13 a.m. EDT. The big jump came after the biotech announced positive interim data from a phase 1 clinical study of novel coronavirus vaccine candidate mRNA-1273.
People across the world are anxiously awaiting good news from the race to develop a COVID-19 vaccine. Moderna's results were admittedly early, but the company's news was certainly good.
Image source: Getty Images.
Source Fool.com